Cure

By Jo Marchant

17 min read

Why does it matter? Because the medicine that could help you most isn't in a pill bottle.

Here's the thing about the placebo effect: you've been thinking about it backwards. It's not the fake treatment researchers use to prove a real drug works. It's the biological response your body already knows how to run, triggered by expectation, ritual, and the presence of someone who seems to give a damn. Once that reframe lands, the list follows naturally: endorphins flooding pain receptors, dopamine surging in Parkinson's patients, immune cells standing down or mobilizing. Modern medicine spent a century learning to subtract these responses from the equation. Cure asks what happened to everything it subtracted. The skeptics who dismiss alternative medicine as theater are largely right. But they're also missing the point: the theater worked, and conventional medicine handed it over without noticing. Marchant's book is about what medicine subtracted — and what it would cost to put it back.

The Placebo Effect Isn't Trickery — It's Biochemistry

Parker Beck was two years old when he stopped smiling. His parents watched him withdraw from the world — no eye contact, no language, head-banging, strange high-pitched screams. Doctors confirmed what they feared: autism. Then in April 1996, Parker received a routine gut endoscopy, and almost overnight he transformed. He started sleeping. He named flashcards. He said 'Mommy' and 'Daddy' for the first time in over a year.

His mother, Victoria, traced the change to a dose of secretin — a gut hormone given during the procedure to check his pancreas. She documented everything on video, wrote letters to researchers, contacted doctors across the country. By October 1998, Parker's story aired on Dateline NBC. Within two weeks, the only licensed U.S. supplier of secretin sold out entirely. Families mortgaged houses. Black-market batches arrived from Mexico and Japan.

Pediatrician Adrian Sandler ran the first rigorous trial — sixty children with autism, half given secretin, half given a saline injection, nobody knowing which was which. The result, published in the New England Journal of Medicine in 1999, was unambiguous: secretin did nothing. No benefit over the fake treatment.

But Sandler noticed something he didn't put in the conclusion. Both groups got better. Children receiving the saline injection dropped from an average score of 63 to 45 on the Autism Behavior Checklist — a nearly 30% improvement within weeks, and in some children the change was dramatic. The parents hadn't imagined it. The kids genuinely improved. Secretin just had nothing to do with it.

The easy read is wishful thinking. But the neuroscience points somewhere more concrete. In Turin, neurologist Fabrizio Benedetti spent decades mapping what actually happens inside the brain when someone receives a placebo. The clearest demonstration came during deep brain stimulation surgery on Parkinson's patients, who remain awake throughout the procedure. With an electrode already monitoring activity in a specific cluster of neurons, Benedetti injected saline and told each patient it was a powerful anti-Parkinson's drug. The neuron recordings told the story without ambiguity: cells that had been firing in uncontrolled, densely packed bursts — a biological signature of Parkinson's — fell to near-silence. Not reduced. Near-silence. Physiologically identical to the effect of the actual drug.

The mechanism had been traced even earlier by researcher Jon Levine, who gave post-surgery patients a saline drip they believed was a potent painkiller. More than a third reported real pain relief. Then Levine administered naloxone, a drug that blocks the brain's natural opioids. The pain came back. The placebo had triggered genuine endorphin release — the same biochemical cascade that morphine produces — and naloxone simply shut it off.

A placebo doesn't fool you into feeling better. It mobilizes actual chemistry through pathways that are measurable, specific, and in some cases physiologically indistinguishable from the drug they're replacing. Belief, under the right conditions, activates the same biological cascades as the drug.

The Real Drug Is the Ritual — and the Person Delivering It

The active ingredient in any medical treatment is meaning — and meaning can be delivered without deception.

Consider what Ted Kaptchuk's team at Harvard told 80 patients with long-term irritable bowel syndrome: the pills in this bottle contain no active ingredient whatsoever. They are placebos. Take them twice a day. The patients — people who had spent years planning grocery runs around bathroom locations — did it anyway, most of them skeptically. And they got significantly better than the patients who received nothing. Linda Buonanno, who had been housebound by cramps and diarrhea for two decades, went to the movies. She had dinner at the Olive Garden. By the third week she was begging her gastroenterologist for more pills. He had to explain that he didn't have ethical approval to keep prescribing them once the trial ended. Three days after she stopped, the symptoms came back.

The conventional explanation for placebo effects — that patients are simply fooled into feeling better — collapses on contact with this result. Linda knew exactly what she was taking. So the question shifts: what was actually doing the work?

Kaptchuk's answer is the ritual itself, and the relationship wrapped around it. When Linda's doctor handed her that bottle, she didn't just take the capsules home — she took home his concern, his attention, the signal that someone with expertise and care was attending to her suffering. The pill was a container for that meaning. Her nervous system, which had been in a state of high alert through years of stress, divorce, caregiving, and job loss, received something it recognized as safety. And it responded accordingly.

A separate trial makes the mechanism even clearer. In a study of 262 IBS patients, Kaptchuk tested not a drug but different layers of clinical attention. Patients who simply enrolled and waited improved 28% — just being seen mattered. Those who received placebo acupuncture from a distant, businesslike practitioner improved 44%. Those who received the same fake acupuncture from a warm, unhurried clinician who sat with them for 45 minutes improved 62%. That last figure is among the strongest results ever recorded for any IBS treatment.

The implication isn't that medicine should swap drugs for kindness. It's that the relationship and the ritual are already doing real biological work — and right now, modern medicine is mostly leaving that lever untouched. The immune system, it turns out, is subject to the same logic: it can be trained, conditioned, and redirected by experience in ways nobody anticipated.

You Can Train Your Immune System Like Pavlov Trained His Dogs

In 1983, an eleven-year-old named Marette Flies was diagnosed with lupus severe enough to be killing her. Her immune system had turned on her whole body — destroying blood-clotting agents, damaging her kidneys, triggering seizures and pneumonia. By the time she was thirteen, her heart was beginning to fail. Her doctors wanted to put her on cytoxan, a toxic immunosuppressant so dangerous that its side effects included cancer and life-threatening infection. It was her only option. But full doses, month after month, might destroy her before the lupus did.

Her mother, a psychologist, had read about Bob Ader's rat experiments. Ader had stumbled onto this while studying taste aversion — rats conditioned to associate saccharin water with an immunosuppressant kept dying after he switched them to plain saccharin. The flavor alone was enough to shut their immune systems down. Conditioning, in other words, wasn't just about salivation and fear responses. It reached all the way into immunology.

Marette's doctors called Ader directly. An emergency ethics board, recognizing that the drug itself posed near-certain harm at full doses, approved something that had never been tried in a human being: a conditioning protocol. Because the stimulus needed to be strange and unmistakable — something Marette's brain would never confuse with ordinary experience — her pediatrician settled on cod liver oil paired with rose perfume. For three months, every time Marette received cytoxan, she swallowed the oil and breathed the perfume. Then the ratio flipped: she got the sensory ritual every month but the actual drug only every third month. By year's end she had received six doses of cytoxan instead of twelve.

Her blood pressure returned to normal. The clotting factor reappeared. She was hospitalized less and less. She graduated high school, drove a sports car, and played trumpet in her college band. She died on Valentine's Day 1995, aged twenty-two — of cardiac damage from her medication — but she had lived years her doctors hadn't expected, on half the drug load they'd feared was unavoidable.

What Marette's case reveals — and what a subsequent trial in psoriasis patients has started to confirm, with conditioning plus quarter-dose corticosteroid matching the results of full-dose controls — is that the immune system isn't a sealed mechanism that only drugs can reach. It's wired directly to the brain through autonomic nerves that run into the spleen and thymus; neuroscientist David Felten found those autonomic nerves threaded directly among immune cells in 1981. That wiring means the immune system can learn. Pair a stimulus with a drug response often enough, and the stimulus starts doing some of the drug's job on its own. The body you thought was simply reacting to chemistry has been keeping notes all along.

Fatigue Is a Brain Alarm — Not a Muscle Failure

Why can Mo Farah complete a set of sit-ups immediately after running the race of his life? At the 2012 London Olympics, seconds after crossing the finish line to win his second gold medal — a 5,000 meters final where he'd held off a surging Ethiopian champion with a blistering last lap — Farah dropped to the track and knocked out the sit-ups with apparent ease, then bounced up to jog his victory lap. If exhaustion meant the body had physically run dry, that sequence would be impossible.

Sports physiologist Tim Noakes at the University of Cape Town spent years trying to find the muscle failure that standard theory promised him. He wired cyclists to measure which fibers were firing as they rode toward exhaustion. The prediction from physiology textbooks, unchanged since Nobel laureate Archibald Hill proposed them in 1923, was that the body should be recruiting every available fiber by the breaking point, squeezing the last drops from a depleted system. Instead, Noakes found the opposite. As his cyclists neared the point where they swore they couldn't continue, the proportion of active fibers was falling — around half remained completely unused. Muscle glycogen dropped significantly but never hit zero. Heart rate at exhaustion still had room to climb. At high altitude, where performance drops sharply, blood oxygen levels stay normal up to about 23,000 feet. The body wasn't failing. Something was shutting it down early.

Noakes's conclusion was that fatigue is a sensation the brain manufactures in advance of any actual damage — a protective alarm, not a distress signal from exhausted tissue. He called the system the central governor. It monitors temperature, oxygen, fuel, and a raft of other variables, then imposes the feeling of exhaustion to keep the body inside a margin of safety. Crucially, it also reads psychological inputs: how far you think you still have to go, whether you're winning or losing, how urgent the need is. Psychologist Chris Beedie tested this directly: he gave elite cyclists a placebo they were told was a performance-enhancing compound, and they rode measurably faster — their average power output climbing by around 3 percent. The brain had recalculated how much effort was safe and loosened its grip.

Noakes extended the same logic to chronic fatigue syndrome, where the governor appears to catastrophically miscalibrate, setting the threshold for safe activity so low that patients become immobilized. Peter White at St. Bartholomew's Hospital in London built a treatment around this: begin with the smallest conceivable activity the patient can manage without crashing — for Samantha Miller, who spent years largely bedridden and at one point asked her family to help her die, that goal was simply turning over in bed once an hour — then increase infinitesimally and consistently over months and years. The idea is to retrain the brain, gradually convincing the central governor that each new activity level is survivable. A 641-person clinical trial published in The Lancet found this approach tripled recovery rates.

Pain Lives in the Brain — Which Means It Can Be Redirected

Every morning at Brooke Army Medical Center in San Antonio, nurses had to scrub dead tissue from the raw wounds covering most of Lieutenant Sam Brown's body. Brown had been burned across his face, hands, and torso when his Humvee hit a roadside bomb in Kandahar in 2008. He'd already survived weeks of sedation, multiple skin-graft surgeries, and the amputation of one finger. But the daily wound-scrubbing sessions were, by his own account, worse than all of it — so unbearable that his superior officers eventually had to make it a direct order. He kept his opioid doses as low as he could stand because he feared addiction more than pain. That left him with almost nothing between himself and the worst experience of his day.

Then a researcher named Hunter Hoffman asked Brown if he'd be willing to try a virtual reality headset during physiotherapy. The world Brown entered — cartoon penguins, woolly mammoths, an ice canyon set to Paul Simon — wasn't remotely realistic. It didn't matter. His worst pain score dropped from 10 to 6. The percentage of time he spent consciously thinking about the pain fell from 76% to 22%. Sessions he'd previously rated as no fun at all became, in his own words, pretty fun. He told Hoffman afterward: 'I think you guys are on to something.'

The mechanism is simpler than it sounds. Anesthesiologist Sam Sharar, who runs the lab where Brown was treated, puts it this way: the brain has a fixed amount of conscious attention, and you cannot expand it. You can only choose where it goes. If that attention is occupied by a vividly convincing virtual world — one that surrounds you above, below, and behind — there's genuinely less processing capacity left for pain. The canyon doesn't eliminate the signal coming from the body. It outcompetes it.

Levine showed that belief triggers real endorphin release. Ader showed that the immune system can be conditioned like a reflex. Noakes showed that exhaustion is a governor set by perception, not a wall hit by muscle. Hoffman's numbers make the same argument in a context where the stakes are hardest to dispute. Attention turns out to be a lever too.

Stress Doesn't Just Feel Bad — It Physically Rewires You

Psychological stress doesn't produce vague, diffuse suffering — it produces specific, measurable biological damage, and in acute cases, it kills.

On the morning of the 1994 Northridge earthquake in Los Angeles, cardiologist Robert Kloner was thrown from his bed by tremors that collapsed apartment buildings and derailed freight trains. The official death toll reached 57. But when Kloner reviewed cardiac death records across the county, he found a second toll hidden in the statistics. In the two weeks before the earthquake, the area averaged 73 cardiac deaths per day. On January 17, that number jumped to 125. Approximately 50 people died of heart attacks that single day with no physical injury — killed, as Kloner concluded, by the perception of mortal threat alone.

That's the acute case. The chronic version is quieter and, over a lifetime, more destructive. When stress never fully resolves — when you're a caregiver for a child with autism, or living in a neighborhood where the next confrontation is unpredictable — the fight-or-flight system stays partially active. Cortisol, released continuously, first suppresses immune function and then loses its own regulatory capacity, allowing inflammation to burn unchecked through blood vessels, joints, and tissue. Researcher Robert Sapolsky describes this chronic inflammation as the central mechanism through which stress kills slowly, contributing to heart disease, diabetes, arthritis, and dementia.

The cellular evidence is even harder to argue with. When Elissa Epel and Elizabeth Blackburn compared mothers of healthy children to mothers of chronically ill children, they found that the most stressed women had telomeres — the protective caps on chromosomes that erode with each cell division — that looked a decade older than those of the least stressed women. Their levels of the enzyme that rebuilds telomeres were also halved. Stress doesn't just make you feel older. It accelerates the molecular process of becoming older.

Here's where it gets complicated, though. Stress researcher Wendy Mendes has shown that the same physiological arousal — racing heart, elevated blood pressure — produces completely different outcomes depending on how you interpret it. Volunteers told before a brutal public-speaking test that their pounding heart meant oxygenated blood was reaching their muscles shifted into what Mendes calls a challenge response: blood vessels dilated, the heart worked efficiently, performance improved. The same physical symptoms, framed differently, produced a different body. When she extended the experiment to students preparing for the graduate school entrance exam, the effect held well beyond the lab — the mindset shift improved their scores on the actual GRE, taken months after the intervention. Mendes called it the most surprising result of her career.

The damage stress causes is real. So is the brain's capacity to alter it.

Loneliness Changes Which Genes Your Immune Cells Express

Consider a woman in her seventies, living alone in Chicago, who scores at the top of every loneliness scale researchers put in front of her. Her immune cells, it turns out, look measurably different from those of someone the same age who feels genuinely connected. That's the finding Steve Cole arrived at — and it's stranger than it sounds.

Cole, a molecular biologist at UCLA, took eight people who had felt profoundly isolated for years and six who described themselves as deeply connected — good friendships, reliable support. He compared which genes were active in their immune cells. Out of roughly 22,000 genes in the human genome, more than 200 showed meaningful differences between the two groups. In the lonely people, genes involved in inflammation were dialed up; genes for fighting viruses and tumors were dialed down. In the connected people, the pattern ran the other way — immune cells organized around fighting disease rather than triggering the kind of chronic internal fire that drives heart disease, diabetes, and dementia.

Here's the detail that sharpens everything: the shift didn't track how many friends someone actually had. It tracked how isolated they felt. A person with a modest social life but no sense of threat showed the healthy profile. Someone sitting in a room full of people but feeling fundamentally alone showed the inflammatory one. The immune system is reading your perception of your social world and restructuring itself accordingly.

Researcher John Cacioppo, who spent decades studying loneliness, argued the wiring makes evolutionary sense. For most of human history, isolation was genuinely dangerous — predators, starvation, no one to defend you. An isolated body prepared for wounds and bacterial infection, diverting resources away from slower threats like viral illness or cancer. Rational then. In a modern context, where the isolation is chronic and the threats are abstract, the same profile turns destructive — inflammation up, antiviral defenses down, and the diseases most likely to kill you left less guarded.

What Cole's result demands is a reclassification. Social connection isn't a comfort that runs parallel to your biology. It is part of the system that determines which version of your immune cells shows up.

The Doctor as Active Ingredient: What a Conversation Can Do That a Drug Cannot

What would you expect monthly conversations to accomplish for someone with terminal lung cancer? Better mood, maybe. A chance to feel heard. Nothing that would show up in survival statistics.

That assumption is what Jennifer Temel's 2010 trial quietly demolished. She followed 150 patients newly diagnosed with terminal lung cancer — median survival, less than a year — and gave half of them standard oncology care. The other half received the same medical treatment plus monthly sessions with a palliative care specialist. Not conversations about tumor markers or treatment schedules. Conversations about what mattered to them: how their families were coping, what they wanted their remaining time to look like, whether aggressive chemotherapy in the final weeks was actually aligned with how they wanted to live. One patient's son was getting married in six months. He probably wouldn't make it. What did he need to say, and to whom?

The patients who had those conversations ended up less depressed, reported better quality of life, and chose less aggressive end-of-life treatment. All of that was expected. What wasn't: they survived an average of 11.6 months, compared to 8.9 months for controls. Monthly conversations about values — not tumors — added nearly three months to a terminal prognosis. The leading explanation is that less last-ditch chemotherapy administered to a failing body actually gives the body more time. Palliative care researcher Vicki Jackson, who ran those sessions, puts the problem plainly: in standard care, accepting aggressive intervention is the only way to signal that you haven't given up. 'Intervention becomes synonymous with hope,' she says. 'And it's not.'

Temel's finding sits alongside Ellen Hodnett's analysis of 22 randomized trials covering 15,000 women in labor. Hodnett found that continuous one-to-one support during labor is the single known intervention that reduces the likelihood of caesarean birth — not a drug, not a device, not a surgical technique. A person staying in the room. Two separate domains, the same structural finding: the quality of human attention in a medical encounter is doing measurable physiological work.

The indictment embedded in all of this is institutional. When Hodnett's trial showed continuous labor support cut surgical rates, hospitals didn't restructure. Hodnett has noted that if the same results had come from a new drug, adoption would have been immediate. Changing chemistry fits the existing model. Changing how people are treated requires reorganizing departments, retraining staff, and accepting that something as unmeasurable-sounding as feeling safe has been quietly functioning as medicine all along.

The Mind Can't Cure Everything — and Believing Otherwise Can Kill You

Tunde Balogh was 37, beautiful by her own account, and dying on principle. When doctors in Ireland diagnosed breast cancer in her right breast, they offered her the full arsenal — radiation, chemotherapy, surgery. She refused every option. 'I knew inside: if I caused this, I can fix this.' She tried reiki. She found German New Medicine, a system built on the claim that cancer originates in unresolved emotional conflict, and that resolving the conflict cures the disease. She spent six months forgiving herself for what she'd done to her own body. By January 2014, the cancer had spread to her bones. By June she could barely walk. Marchant meets her in Lourdes in a wheelchair, still searching, still convinced the answer was inside her if she could only reach it.

The earlier chapters of this book are full of genuine evidence that belief shapes biology — that expectations release endorphins, that loneliness rewires immune cells, that dopamine floods a Parkinson's patient's brain after a saline injection. All of that is real. But Fabrizio Benedetti, who spent his career demonstrating those effects in the most rigorous possible terms, also mapped their limits precisely. What the brain can do is mobilize the body's existing resources — endorphins, dopamine, prostaglandins — in response to expectation. What it cannot do is manufacture what isn't there. Across seven placebo-controlled cancer trials, tumor shrinkage in the placebo groups came in at 2.7%. The mind can ease pain. It can reduce nausea. It cannot dissolve a malignancy. And a woman with early-stage breast cancer, still treatable, who reframes her oncologist's offer as an insult to her inner resources — she doesn't lose a coin flip. She forfeits the treatment entirely.

The mind-body argument is most powerful when it operates inside medicine, not as a replacement for it: adding palliative conversations to chemotherapy, training attention away from pain during wound debridement, conditioning the immune system to extend a drug regimen. The moment it tips into a reason to refuse medicine entirely, it stops being science and starts being something that kills people.

What Medicine Already Knows and Won't Prescribe

Here is the real puzzle, once you've absorbed all of this: the science isn't missing. It's sitting in peer-reviewed journals, produced by researchers at Harvard and UCLA and the University of Cape Town, funded in many cases by the same institutions that run conventional medicine. The gap between what we know and what gets practiced isn't a knowledge problem. It's a money problem. You can patent a molecule. You can run a controlled trial on a drug and charge for the result. You cannot patent a warm clinician, a conditioning ritual, or the feeling of being genuinely heard — so nobody funds the trial at scale, nobody builds the infrastructure, and the lever goes untouched. Meanwhile, the United States spent over $80 billion on opioid-related costs in a single year while cheaper, lower-risk tools sat documented and largely ignored in the literature. The question worth leaving with isn't whether your mind affects your body. That's settled. The question is why a system built on healing has so little financial incentive to use the most cost-effective tools it already has — and what you do with that the next time you're sitting in a waiting room, wondering whether to ask your doctor for something stronger or just to be listened to a little longer.